Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alvotech (ALVO) Other Accumulated Expenses (2020 - 2025)

Alvotech filings provide 6 years of Other Accumulated Expenses readings, the most recent being $100.4 million for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 98.72% to $100.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $100.4 million, a 98.72% increase, with the full-year FY2024 number at $59.4 million, down 5.29% from a year prior.
  • Other Accumulated Expenses hit $100.4 million in Q3 2025 for Alvotech, up from $73.1 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $100.4 million in Q3 2025 to a low of $42.0 million in Q4 2021.
  • Median Other Accumulated Expenses over the past 5 years was $64.6 million (2025), compared with a mean of $67.1 million.
  • Biggest five-year swings in Other Accumulated Expenses: surged 155.92% in 2021 and later decreased 27.1% in 2024.
  • Alvotech's Other Accumulated Expenses stood at $42.0 million in 2021, then grew by 28.65% to $54.0 million in 2022, then increased by 16.05% to $62.7 million in 2023, then fell by 5.29% to $59.4 million in 2024, then skyrocketed by 68.97% to $100.4 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $100.4 million (Q3 2025), $73.1 million (Q2 2025), and $64.6 million (Q1 2025) per Business Quant data.